Carisma Therapeutics

1 follower


Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy to treat solid tumors.

Industries

Headquarters

Stage

Employees

Links

Org chart

Steven Kelly
President & CEO

Steven Kelly

Collapse
Michael Klichinsky
Co-Founder & SVP, Discovery Research
Richard Morris
Chief Financial Officer
Tom Wilton
Chief Business Officer
Eric Siegel
General Counsel & Corporate Secretary
Terry Shields
SVP, Human Resources
Kenneth Locke
VP, Manufacturing & Supply Chain
Maggie Wesberry Schmierer
Director, Analytical Sciences And Quality Control
Hameem Mazahreh
Senior Manager, Quality Assurance
Andrew Best
Manager, Process Development
Isaac Zentner
Associate Director, Process Development
Nicholas Minutolo
Associate Director, Research